Davis's Drug Guide

abciximab

Contraindication/Precautions

Contraindicated in:

• Hypersensitivity to abciximab or murine (mouse) protein

• Active internal bleeding

• Recent significant GI or GU bleeding (within 6 wk)

• History of CVA (within 2 yr) or CVA with neurologic sequelae

• History of bleeding disorder

• Recent (within 7 days) oral anticoagulant therapy (PT >=1.2 times control)

• Platelet count <100,000 cells/mm³

• Recent trauma or major surgery (within 6 wk)

• Intracranial neoplasm

• Aneurysm or AV malformation

• Severe uncontrolled hypertension

• History of vasculitis

• Concurrent use of another parenteral GP IIb/IIIa inhibitor

• Recent or concurrent dextran therapy



Use Cautiously in:

• Patients weighing <75 kg or >65 yr (increased risk of bleeding)

• History of previous GI pathology

• Concurrent thrombolytic or heparin therapy

• PCI within 12 hr of onset of MI symptoms or PCI procedure lasting >70 min

OB: Lactation: Pedi: Safety not established



abciximab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.

Content Manager
Search Unbound MEDLINE
Display all Sections
Font Size
PrintSectionTopic
Related Content
enoxaparin
eptifibatide
tenecteplase
bivalirudin

more ...